Judges Scientific Share Price (JDG.L): Live Chart & News

Judges Scientific stock has been on a wild ride, with its share price swinging from 11,225.00 GBX highs last September to multi-year lows this year. The AIM-listed scientific instruments group offers a compelling case study in AIM volatility — and the ticker JDG.L has plenty to unpack about where it stands now and what moves might come next.

Buy Price: 4,650.00p · Sell Price: 4,630.00p · Market Cap: £309.71m · P/E Ratio: 57.13 · Dividend Yield: 2.34%

The key metrics below summarise the stock’s current financial profile based on official data sources.

Judges Scientific share price history

The trajectory of JDG.L over the past year reads like a cautionary tale about AIM volatility. The 52-week high came on 04-Sep-2024, when the shares touched 9,120.00p — though some platforms recorded intraday peaks reaching 11,225.00 GBX (StockAnalysis.com). From those levels, the stock has surrendered substantial ground, with the 52-week low touching 3,480.00p on weaker days (AJ Bell).

What makes the price action particularly tricky to track is the variance across platforms. The company’s own investor relations site showed 4,780.00p at 13:46:56 on one day and dropped to 4,050.00p by early morning — a swing that reflects real-time liquidity constraints common on AIM listings (Judges Scientific plc). Hargreaves Lansdown reported a recent price of 4,650.00 GBX, while other feeds showed modest gains of around 1.09% (Hargreaves Lansdown).

Despite the turbulence, Judges Scientific actually outperformed the FTSE AIM 100 benchmark, delivering a +1.09% total return compared to the index’s -0.64% over the same period (AJ Bell). That’s worth keeping in perspective — relative strength can matter as much as absolute price movement for long-term holders.

Recent price changes

The gap between buy and sell prices — currently around 20p — illustrates the wide spreads investors face when trading AIM stocks. Where the buy price sits at 4,650.00p, the sell side offers 4,630.00p, meaning any immediate seller effectively cedes 0.43% to the spread. For larger position holders looking to exit, that cost compounds quickly.

Historical charts

With 6,651,052 shares of 5 pence each in issue as of December 2025, the issued share capital hasn’t changed dramatically — the price movement reflects market valuation shifts rather than dilution events (Judges Scientific plc). The ISIN GB0032398678 identifies the stock uniquely for settlement purposes (AJ Bell).

Judges Scientific share price forecast

Analysts tracking JDG.L have set a median 12-month price target of 7,000.00 GBX, according to the Investors Chronicle data — representing meaningful upside from current levels if the shares can recover (Investors Chronicle). The range, however, tells a more cautious story: individual broker estimates span from 5,600.00 to 7,380.00 GBX, a spread that reflects genuine uncertainty about execution timing.

One alternative consensus view pegs the median target at 6,000.00 GBX, implying a 66.67% increase from the 4,200.00 GBX baseline — though this estimate carries lower confidence given sourcing from secondary platforms (Investors Chronicle). The divergence between sources underscores why investors should check multiple analyst views rather than anchoring to a single forecast.

Analyst predictions

The analyst community appears divided on near-term catalysts. Materials Sciences and Vacuum segments serve customers ranging from higher education institutions to regulatory authorities, but the geographic breakdown remains broad — UK, Rest of Europe, North America, and Rest of World — without granular revenue weighting that would help investors assess sector exposure (AJ Bell).

Future outlook

The company’s acquisition model — buying and developing scientific instrument businesses — theoretically supports earnings growth, but the lack of recent M&A announcements or detailed portfolio company updates leaves the market without concrete evidence of pipeline progress. Next concrete data point: earnings scheduled for 18-Sep-2025 (StockAnalysis.com).

Judges Scientific market cap

At £309.71 million, Judges Scientific commands a mid-cap position on AIM — substantial enough to attract institutional interest, yet small enough that liquidity constraints can amplify price swings (LSE.co.uk). With a P/E ratio of 57.13, the valuation sits at a premium to broader market averages, pricing in expectations for the acquisition strategy to deliver earnings growth.

The dividend yield of 2.34% offers some income cushion for patient holders, though the absolute payout depends on maintaining the interim rate of 32.70p (ex-date 09/10/2025) and final rate of 82.30p (ex-date 11/06/2026) (AJ Bell). At current prices, the annualized payout looks sustainable given trailing net income figures, but margin compression could pressure future distributions.

Current valuation

The Price/Sales ratio of 2.13 implies the market is pricing the company at roughly twice annual revenue — reasonable for a niche scientific instruments platform, though elevated relative to broader industrial averages (AJ Bell). Revenue TTM of £133.60M against that £309.71M market cap creates the multiple, with Net Income TTM reported at £10.40M providing the earnings base (StockAnalysis.com).

Comparison metrics

With a beta of 0.69, JDG.L has historically moved less than the broader market — though the past year’s price action suggests that relationship has broken down during the drawdown phase (StockAnalysis.com). EPS TTM of 1.54 gives an earnings yield of roughly 3.1% at current prices, though P/E calculations vary significantly between sources — AJ Bell reports 57.13 while Hargreaves Lansdown puts it at 16.71, a discrepancy that warrants investigation (AJ Bell).

Judges Scientific News

The official Judges Scientific investor relations site maintains a dedicated share price and RNS announcements page, though the current dataset doesn’t include specific recent news events or regulatory announcements beyond the shareholder disclosures filed as of December 2025 (Judges Scientific plc). Investors seeking real-time regulatory news service updates should bookmark the RNS feed directly.

The dividend calendar provides concrete upcoming dates: holders who want to receive the 32.70p interim dividend must own shares before the ex-dividend date of 09/10/2025, with payment arriving 07/11/2025 (AJ Bell). The final dividend adds another 82.30p with ex-date 11/06/2026 and payment 10/07/2026.

Latest announcements

Shareholder disclosures as of December 2025 revealed that 10.63% of ordinary shares are not in public hands — meaning nearly 700,000 shares are held by insiders or related parties (Judges Scientific plc). This restricted float affects liquidity and can create price dislocations when large shareholders adjust positions.

RNS updates

The company operates under the UK City Code on Takeovers and Mergers, providing certain governance protections for minority holders (Judges Scientific plc). All shares carry equal voting rights with no transfer restrictions on AIM, meaning the stock remains freely tradeable despite the reduced public float.

Judges Scientific LSE

Judges Scientific trades on the London Stock Exchange AIM market under the ticker JDG.L — meaning it’s outside the main market’s premium listing segment and carries the additional risks associated with Alternative Investment Market companies (LSE.co.uk). AIM stocks typically face lighter regulatory requirements than main market listings, though Judges Scientific voluntarily adheres to the Takeover Code.

The stock settles through standard UK equity infrastructure: ISIN GB0032398678 identifies the security for trade matching and custody purposes (AJ Bell). Quoted in GBX (pence) rather than pounds, the 4,650.00p current level translates to £46.50 per share in sterling terms.

Listing details

The company’s official site describes its business as “an AIM-quoted group specialising in the acquisition and development of a portfolio of scientific instrument businesses” — a holding company model that contrasts with operational peers in the scientific instruments sector (Judges Scientific plc). Products reach higher education, scientific communities, manufacturers, and regulatory authorities.

Trading info

The share structure consists entirely of ordinary shares with no preference shares or multiple share classes — all shares carry equal voting rights with no transfer restrictions on AIM (Judges Scientific plc). For investors placing trades, the ticker JDG.L works across most UK brokers and international platforms that support LSE AIM listings.

Shareholder structure and ownership

Two large shareholders anchor the register: Director David Cicurel holds 610,389 ordinary shares, representing a 9.2% stake as of December 2025 — including SIPP and SIP holdings plus 67,000 non-beneficial shares — while institutional investor Odin Global accounts for 590,000 shares (8.9%) (Judges Scientific plc). Together, these two holders control nearly 18% of the company, creating significant aligned interests in any strategic decisions.

Upcoming dates

Three dates matter for the calendar: earnings release on 18-Sep-2025, interim dividend ex-date 09/10/2025, and final dividend ex-date 11/06/2026 (AJ Bell). The dividend schedule provides regular cash return milestones that could support the share price at current levels if maintained.

How JDG.L compares to peers

Judges Scientific operates across Materials Sciences and Vacuum segments, competing with both niche scientific instrument makers and broader industrial measurement companies. The acquisition strategy differentiates it from organic-growth peers, though comparing P/E ratios requires accounting for the holding company structure. The FTSE AIM 100 comparison (+1.09% total return vs -0.64%) suggests the stock held up better than the index during the recent period, though absolute performance remains negative.

Judges Scientific plc is an AIM-quoted group specialising in the acquisition and development of a portfolio of scientific instrument businesses.

— Judges Scientific plc (Official Company Site)

The whole of the Company’s issued Ordinary Share capital (comprising 6,651,052 shares of 5 pence each, none of which are held as treasury shares) is traded only on the AIM market.

— Judges Scientific plc (Official Disclosures)

For UK investors weighing JDG.L against other AIM opportunities, the combination of dividend yield (2.34%), analyst target upside (5,600.00-7,380.00 GBX range), and insider ownership (Cicurel’s 9.2%) creates a mixed picture — more attractive than index funds but requiring active conviction in the acquisition pipeline delivering results.

Related reading: BAE Systems share price

Investors monitoring Judges Scientific (JDG.L) performance often track the Oxford Instruments share price as another key player in scientific instruments on the LSE.

Frequently asked questions

For UK retail investors tracking JDG.L, the path forward is straightforward: watch the September earnings report for concrete evidence of whether the acquisition model can restore growth, monitor any director dealings for insider signals, and consider the dividend schedule as a partial floor beneath the current price level.